Giant Gastric Gastrointestinal Stromal Tumor (GIST)
dc.contributor.author | Navarrete, Andres | |
dc.contributor.author | Momblan, Dulce | |
dc.contributor.author | Almenara, Raul | |
dc.contributor.author | Lacy, Antonio | |
dc.date.accessioned | 2017-08-16T13:33:30Z | |
dc.date.available | 2017-08-16T13:33:30Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Gastrointestinal stromal tumors (GIST) represent 0.1–3 % of gastrointestinal malignancy. Surgery is the mainstay of treatment, but in high-risk tumors, imatinib can help to achieve better oncological outcomes. We present a rare case of a patient with gastric GIST with very aggressive evolution in a short period of time despite the use of neoadjuvant therapy with imatinib. | |
dc.format.extent | 3 | |
dc.identifier.citation | J Gastrointest Surg (2017) 21:202-204 | |
dc.identifier.uri | http://hdl.handle.net/11447/1578 | |
dc.identifier.uri | http://dx.doi.org/10.1007/s11605-016-3196-x | |
dc.language.iso | en_US | |
dc.publisher | Springer | |
dc.subject | GIST | |
dc.subject | Gastric | |
dc.subject | Imatinib | |
dc.title | Giant Gastric Gastrointestinal Stromal Tumor (GIST) | |
dc.type | Artículo |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Giant Gastric Gastrointestinal Stromal Tumor .pdf
- Size:
- 173.91 KB
- Format:
- Adobe Portable Document Format
- Description:
- Resumen